Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yili Chuanning Biotechnology is a leading Chinese biotech and pharmaceutical manufacturer specializing in the research, development, and industrialization of biological fermentation technologies. The company produces key antibiotic intermediates (erythromycin thiocyanate, cephalosporin/penicillin intermediates), ursodeoxycholic acid, coenzyme Q10 mycelium, and other APIs. It has significant production capacity for both domestic use and export markets. The company is recognized for its environmental initiatives in waste treatment during antibiotic production[1][2][3][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yili Chuanning Biotechnology.